Brief: Deutsche Biotech Innovativ: Three Main Shareholders Divest Up To 15% Of Shares
Aug 19 (Reuters) - DEUTSCHE BIOTECH INNOVATIV AG DBIG.F :
* FURTHER STEP TOWARDS A STRONG CAPITAL MARKET ORIENTATION -
INCREASE OF THE SHARES AVAILABLE IN 'FREE FLOAT'
* THREE MAIN SHAREHOLDERS OF DBI AG HAVE DECIDED TO DIVEST A
TOTAL
OF UP TO 15% OF THEIR SHARES IN ORDER TO INCREASE FREE FLOAT
Source text for Eikon: ID:nEQ2q6Fza
Further company coverage: DBIG.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Deutsche Biotech Innovativ AG
See all newsBrief: Deutsche Biotech Innovativ Positive Results Of Phase II Study Adrenomed Adrenoss-2
Brief: Deutsche Biotech Innovativ Says Adrenomed's Antibody Adrecizumab From Shows Positive Effect In COVID-19 Patients
Brief: Deutsche Biotech Innovativ Signs Convertible Loan Agreement With SphingoTec
Brief: Deutsche Biotech Innovativ: Three Main Shareholders Divest Up To 15% Of Shares
Brief: Deutsche Biotech Innovativ Appoints Ralf M. Jakobs As New CFO